Advanced Biohealing (ABHB) Sees IPO Price of $14 - $16/Share
Tweet
Share
E-mail
Advanced Biohealing, Inc. (Nasdaq: ABHB) filed an amended registration statement with the U.S. Securities and Exchange Commission today for an Initial Public Offering of its Ordinary Shares. Advanced Biohealing plans to sell 13,350,000 shares and sees an initial price of $14 - $16 per share. Advanced Biohealing has filed to list on the Nasdaq Global Market under the ticker "ABHB."
The offering is being made through BofA/Merrill Lynch, J.P. Morgan, Wells Fargo Securities, William Blair & Co., and Oppenheimer & Co.
Advanced Biohealing is a regenerative medicine company that develops, manufactures and commercializes cell-based therapies.
The offering is being made through BofA/Merrill Lynch, J.P. Morgan, Wells Fargo Securities, William Blair & Co., and Oppenheimer & Co.
Advanced Biohealing is a regenerative medicine company that develops, manufactures and commercializes cell-based therapies.
Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!
Create E-mail Alert Related Categories
IPOsRelated Entities
William Blair, JPMorgan, Merrill Lynch, Bank of America, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
